0423 The use of evidence-based medicine (EBM) to assess the benefit-to-risk of disease-modifying drugs (DMDs) in multiple sclerosis (MS)

• Book ID: 119466967
• Publisher: Elsevier Science
• Year: 2005
• Tongue: English
• Weight: 124 KB
• Volume: 238
• Category: Article
• ISSN: 0022-510X
• DOI: 10.1016/s0022-510x(05)80790-7